Cargando…

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes

Detalles Bibliográficos
Autor principal:	Vora, Jiten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Insulin Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920804/ https://www.ncbi.nlm.nih.gov/pubmed/23882050 http://dx.doi.org/10.2337/dcS13-2036

Ejemplares similares

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
por: Yki-Järvinen, Hannele, et al.
Publicado: (2013)

Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?
por: Del Prato, Stefano, et al.
Publicado: (2013)

Early Insulinization to Prevent Diabetes Progression
por: Raz, Itamar, et al.
Publicado: (2013)

Emerging role of insulin with incretin therapies for management of type 2 diabetes
por: Ahluwalia, Rupa, et al.
Publicado: (2011)

Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 2013;36(Suppl. 2):S226–S232
por: Vora, J
Publicado: (2013)

Association of three insulin resistance indices with hypertension and body weight among Uyghur adults in rural areas of Xinjiang, China
por: Mao, YiDan, et al.
Publicado: (2022)

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
por: Bellido, Virginia, et al.
Publicado: (2015)

How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment
por: Gallwitz, Baptist, et al.
Publicado: (2013)

Developing a Simple 3-Day Insulin Delivery Device to Meet the Needs of People With Type 2 Diabetes
por: Lilly, Leslie C., et al.
Publicado: (2018)

Digital Diabetes Management: A Literature Review of Smart Insulin Pens
por: Heinemann, Lutz, et al.
Publicado: (2021)

Insulin’s Role in Diabetes Management: After 90 Years, Still Considered the Essential “Black Dress”
por: Cefalu, William T., et al.
Publicado: (2015)

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018)

Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary
por: Sparre, Thomas, et al.
Publicado: (2022)

Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes
por: Pratley, Richard E., et al.
Publicado: (2017)

Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity
por: Patel, S. A., et al.
Publicado: (2012)

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
por: Groeneveld, Onno N, et al.
Publicado: (2015)

Second-Generation Insulin Analogues – a Review of Recent Real-World Data and Forthcoming Head-to-Head Comparisons
por: Mauricio, Didac, et al.
Publicado: (2018)

Glutamine Triggers and Potentiates Glucagon-Like Peptide-1 Secretion by Raising Cytosolic Ca(2+) and cAMP
por: Tolhurst, Gwen, et al.
Publicado: (2011)

The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
por: Vora, Jiten, et al.
Publicado: (2014)

Impaired Musculoskeletal Response to Age and Exercise in PPARβ(−/−) Diabetic Mice
por: Fu, He, et al.
Publicado: (2014)

Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
por: Agarwalla, Anjali, et al.
Publicado: (2022)

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom
por: Gordon, Jason, et al.
Publicado: (2013)

Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
por: Gracia‐Ramos, Abraham Edgar
Publicado: (2019)

Accumulation of childhood adversities and type 1 diabetes risk: a register-based cohort study of all children born in Denmark between 1980 and 2015
por: Bengtsson, Jessica, et al.
Publicado: (2020)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
por: Derosa, Giuseppe, et al.
Publicado: (2007)

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
por: Drucker, Daniel J., et al.
Publicado: (2010)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz, Stanley, et al.
Publicado: (2010)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
por: Khoo, Joan, et al.
Publicado: (2009)

Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
por: Nisal, Kaustubh, et al.
Publicado: (2012)

Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes
por: Tibaldi, Joseph M.
Publicado: (2014)

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes
por: Barrientos‐Pérez, Margarita, et al.
Publicado: (2022)

Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications
por: Peters, Sanne A. E., et al.
Publicado: (2015)

Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
por: Müssig, Karsten, et al.
Publicado: (2009)

Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth‐onset type 2 diabetes
por: Reid, Lauren A., et al.
Publicado: (2022)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis
por: Terawaki, Yuichi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qdvq1tafsjjv9ilvjtrm3a545e